Carregant...
Liquid Biopsies for Assessing Metastatic Melanoma Progression
The field of genomic biomarkers in melanoma has evolved dramatically in the past few decades. Whereas much of the prior focus has been on molecular assessment of tumor tissue, circulating tumor cells (CTCs) and cell-free circulating tumor DNA (ctDNA) as sources of a “liquid biopsy” in cancer patient...
Guardat en:
| Publicat a: | Crit Rev Oncog |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5326707/ https://ncbi.nlm.nih.gov/pubmed/27481010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/CritRevOncog.2016016075 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|